Our company has started working on new projects:

• Smooth Drug Development starts working on documentation for a phase three study in fatty degeneration of liver for a Russian company.
• Our company prepares for an observational program of cosmetics in patients with atopy for a European company.
• Smooth Drug Development was awarded a bioequivalence trial of (INN: Etoricoxib) for an international pharmaceutical company.
• Our company was awarded with an observational study in hemorrhoid, held by one of the major players on the international pharmaceutical market.